Express Pharma - Page 57 of 2240 - Express Pharma

Government caps margins on cancer medicines at 30%, targets ₹2,500 Cr annual savings

Lupin receives USFDA approval for Phytonadione Injectable Emulsion

Why industry-academia collaboration will shape India’s next R&D chapter

PAGE partners with 8chili to launch AI and VR training platform for pharma manufacturing in India

Safeguarding the pharma excipients supply chain

Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility

Off label drug use and physician liability

Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States

Zyax Chem acquires 26% stake in Gaymed Labs

OneSource and Orbicular secure USFDA tentative approval for generic semaglutide injection

India’s biopharma moment—If we get the ecosystem right

Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483

Clinical exclusivity for indigenous medicines can improve long-term affordability and access